CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart Disease Major trials in coronary intervention from 2018 Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

Review Article2003 Oct;60(2):194-201.

JOURNAL:Catheter Cardiovasc Interv. Article Link

Society of cardiac angiography and interventions: suggested management of the no-reflow phenomenon in the cardiac catheterization laboratory

Klein LW, Kern MJ, Interventional Cardiology Committee of the Society of Cardiac Angiography and Interventions. Keywords: no-reflow phenomenon; CathLab

LINK

Please click on "Article Link" on the right side to get further access.